Dr. Powell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin St
# MS205
Houston, TX 77030Phone+1 713-394-6450Fax+1 713-441-3886
Education & Training
- University of FloridaFellowship, Neuropathology, 1993 - 1995
- University of Florida College of Medicine JacksonvilleResidency, Pathology-Anatomic and Clinical, 1989 - 1993
- West Virginia University School of MedicineClass of 1988
Certifications & Licensure
- FL State Medical License 1990 - 2026
- TX State Medical License 1998 - 2026
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Clinical Trials
- CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM Start of enrollment: 2010 Oct 01
Publications & Presentations
PubMed
- 559 citationsHER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation TrialNabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra
JAMA Oncology. 2017-08-01 - 190 citationsT cells redirected to EphA2 for the immunotherapy of glioblastoma.Kevin Chow, Swati Naik, Sunitha Kakarla, Vita S. Brawley, Donald R. Shaffer
Molecular Therapy. 2013-03-01 - 156 citationsSingle-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target.Nourhan Abdelfattah, Parveen Kumar, Caiyi Wang, Jia-Shiun Leu, William F Flynn
Nature Communications. 2022-02-09
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: